Cervical cancer medical therapy: Difference between revisions
No edit summary |
No edit summary |
||
| Line 13: | Line 13: | ||
On June 15, 2006, the US [[Food and Drug Administration]] approved the use of a combination of two chemotherapy drugs, [[hycamtin]] and [[cisplatin]] for women with late-stage (IVB) cervical cancer treatment.<ref>[http://www.fda.gov/bbs/topics/NEWS/2006/NEW01391.html]</ref> Combination treatment has significant risk of [[neutropenia]], [[anemia]], and [[thrombocytopenia]] side effects. Hycamtin is manufactured by GlaxoSmithKline. | On June 15, 2006, the US [[Food and Drug Administration]] approved the use of a combination of two chemotherapy drugs, [[hycamtin]] and [[cisplatin]] for women with late-stage (IVB) cervical cancer treatment.<ref>[http://www.fda.gov/bbs/topics/NEWS/2006/NEW01391.html]</ref> Combination treatment has significant risk of [[neutropenia]], [[anemia]], and [[thrombocytopenia]] side effects. Hycamtin is manufactured by GlaxoSmithKline. | ||
====Contraindicated medications==== | |||
{{MedCondContrAbs|MedCond =Invasive cervical carcinoma|Oxytocin}} | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 18:11, 10 December 2014
|
Cervical cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cervical cancer medical therapy On the Web |
|
American Roentgen Ray Society Images of Cervical cancer medical therapy |
|
Risk calculators and risk factors for Cervical cancer medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]
Medical Therapy
Women with cervical cancer have many treatment options. The options are surgery, radiation therapy, chemotherapy, or a combination of methods. The choice of treatment depends mainly on the size of the tumor and whether the cancer has spread. The treatment choice may also depend on whether you would like to become pregnant someday.
Radiation and Chemotherapy
Larger early stage tumors (IB2 and IIA more than 4 cm) may be treated with radiation therapy and cisplatin-based chemotherapy, hysterectomy (which then usually requires adjuvant radiation therapy), or cisplatin chemotherapy followed by hysterectomy.
Advanced stage tumors (IIB-IVA) are treated with radiation therapy and cisplatin-based chemotherapy.
On June 15, 2006, the US Food and Drug Administration approved the use of a combination of two chemotherapy drugs, hycamtin and cisplatin for women with late-stage (IVB) cervical cancer treatment.[1] Combination treatment has significant risk of neutropenia, anemia, and thrombocytopenia side effects. Hycamtin is manufactured by GlaxoSmithKline.
Contraindicated medications
Invasive cervical carcinoma is considered an absolute contraindication to the use of the following medications: